At LifeX, the world's leading minds come together to solve our biggest health problems.
The revolutionary solutions we develop have the potential to alleviate mass suffering and death on a global scale.
The platform is made up of two independent entities: LifeX Labs and LifeX Capital. These organizations synergize to drive solutions from innovators into the marketplace.
HEALTHCARE HAS TO CHANGE, BECAUSE IF WE FAIL TO ACT...
Over half of adults currently under 65 will be diagnosed with cancer1
By 2050, resistance to antibiotics will kill more people than cancer2
65 million more adults in the US will be obese by 20303
IT'S OUR MISSION TO SIGNIFICANTLY REDUCE THE GLOBAL DISEASE BURDEN
Complex illnesses are putting an unprecedented strain on healthcare systems that are already stretched. At LifeX, we believe we can change this.
Where others might see issues that are just too vast and too difficult, we see solvable problems.
SUCCESS WILL BE MEASURED IN THE NUMBER OF LIVES WE IMPROVE, NOT ONLY THE AMOUNT OF MONEY WE MAKE.
Dr. Dietrich Stephan Ph.D., LifeX CEO and Founder
LifeX is made up of three complementary ventures:
THE LABS ARE OUR HOME
We build companies. We chose our home in Pittsburgh, but the impact of what we do here is felt around the globe. Labs provides infrastructure and expertise that’s nurturing the next generation of biotech companies. The Labs are supported by the University of Pittsburgh.
BIG IS BEAUTIFUL
The Capital Funds are separate and independent from LifeX Labs, but co-located, and provide equity financing to transform innovation with high potential into exponential companies with world class talent drawn upon regional and national innovation. The opportunities range from early stage investment with the Capital Fund to syndication with other investors, all with an eye to scale.
STORIES OF SUCCESS
Companies in the LifeX Portfolio have three things in common: they address large market needs, have innovation based on technology convergence and billion-dollar potential. This trail-blazing group have been funded by LifeX Capital or facilitated by LifeX Labs.
PITTSBURGH FOUNDED COMPANY SPOTLIGHT: DIAVACS
LifeX represents a one-of-a-kind opportunity. It’s about realizing potential and making a tangible difference to those who suffer and die across the globe.
We have built a forward-thinking portfolio, with first-in-class solutions and the proven ability to earn significant financial returns.
The University of Pittsburgh and its Graduate School of Public Health together with the Henry L. Hillman Foundation support LifeX Labs.
1. Ahmad AS et al. Brit J Cancer 2015; 112: 943–947. 2.The Review on Antimicrobial Resistance 2016 https://amr-review.org Accessed April 2018. 3. 'Half of UK obese by 2030' https://www.nhs.uk/news/obesity/half-of-uk-obese-by-2030/ Accessed April 2018.